China: Shanxi Province issues compulsory immunization plan for animal diseases in 2024

Published Feb 6, 2024

Tridge summary

The Shanxi Provincial Department of Agriculture and Rural Affairs in China has developed a '2024 Compulsory Immunization Plan for Animal Diseases' to maintain herd immunity for several diseases at over 90% throughout the year. The plan includes training, improving breeding immunity records, implementing an information reporting system, and carrying out immune effect assessments. The 'strike first and make up later' policy will be fully implemented in large-scale breeding farms by 2024. The article also lists various strains of vaccines for diseases like Swine Fever and Newcastle disease.
Disclaimer: The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

In order to effectively carry out the province's compulsory immunization against animal diseases in 2024, in accordance with the "Animal Epidemic Prevention Law of the People's Republic of China" and the "Notice of the Ministry of Agriculture and Rural Affairs on the issuance of the "National Guidelines for Compulsory Immunization against Animal Diseases (2022-2025)" (Agriculture and Rural Affairs) Mufa [2022] No. 1), combined with the actual situation of Shanxi Province, the Shanxi Provincial Department of Agriculture and Rural Affairs formulated the "2024 Compulsory Immunization Plan for Animal Diseases", the specific contents are as follows. ​ ​ ​ ​ ​ ​ ​ 2024 Compulsory Immunization Plan for Animal Diseases In order to fully implement the spirit of the "Animal Epidemic Prevention Law of the People's Republic of China" and the "Notice of the Ministry of Agriculture and Rural Affairs on Issuing the "National Compulsory Immunization Guidelines for Animal Diseases (2022-2025)" ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.